论文部分内容阅读
目的 :观察胸膜腔内置引流管注入尿激酶治疗结核性包裹性胸水效果。方法 :在应用规则抗结核治疗基础上 ,对 34例结核性包裹性胸液患者经内置引流管胸腔内注射尿激酶 10万单位 ,另外 34例胸腔内注入地塞米松 5 mg作对照。结果 :治疗组 34例中有 2 7例 (80 % )达到显效 ,7例 (2 1% )好转 ,无效 0例 ,总有效率 10 0 %。结论 :通过胸腔内置引流管注入尿激酶治疗结核性包裹性胸腔积液可以增加引流量 ,减轻胸膜肥厚 ,改善肺功能 ,减少穿刺机会 ,减轻患者痛苦 ,疗效显著。
Objective: To observe the effect of injecting urokinase into the pleural cavity to treat tuberculous pleural effusion. Methods: Thirty-four patients with tuberculous encapsulated pleural effusion were injected with 10 000 units of urokinase through the thoracic cavity of the drainage tube and 34 of them were injected with 5 mg of dexamethasone for control. Results: Twenty-seven of the 34 patients (80%) in the treatment group achieved marked improvement, 7 (21%) improved, 0 failed and the total effective rate was 100%. Conclusion: The injection of urokinase into pleural effusion into tuberculous pleural effusion can increase drainage, reduce pleural thickening, improve lung function, reduce the chance of pricking and relieve the pain of patients with significant curative effect.